MDT - Medtronic plc

NYSE - NYSE Delayed Price. Currency in USD
86.81
+0.51 (+0.59%)
At close: 4:03PM EDT

86.81 0.00 (0.00%)
After hours: 4:43PM EDT

Stock chart is not supported by your current browser
Previous Close86.30
Open86.66
Bid85.25 x 1300
Ask88.35 x 4000
Day's Range86.61 - 87.58
52 Week Range76.41 - 89.72
Volume5,573,760
Avg. Volume4,757,062
Market Cap117.56B
Beta0.75
PE Ratio (TTM)38.24
EPS (TTM)2.27
Earnings DateAug 21, 2018
Forward Dividend & Yield1.84 (2.12%)
Ex-Dividend Date2018-03-22
1y Target Est94.55
Trade prices are not sourced from all markets
  • United Rentals, Blackberry and Medtronic are the Yahoo Finance charts of the day.
    Yahoo Finance Video8 hours ago

    United Rentals, Blackberry and Medtronic are the Yahoo Finance charts of the day.

    Let's check out the Yahoo Finance charts of the day. United Rentals (URI): Shares are up in early trade, at around 3.6%.  UBS upgraded the equipment rental company to "buy" from "neutral". UBS said cyclical and cost concerns surrounding the company are overdone. Blackberry (BB): Shares down here, at 6.9%.  The software and services company saw revenue top estimates. Blackberry reported adjusted first-quarter profit of 3 cents per share, compared to analysts' expectations of a breakeven quarter. Medtronic (MDT): Shares are up slightly here, at around .82%.  The medical device company said Friday its board has approved a 9% increase in its quarterly cash dividend to 50 cents a share. For more on today's big stock movers check out the Final Round, live at 3:55 p.m. ET, right here on Yahoo Finance.

  • United Rentals gets an upgrade, Blackberry dips, Medtronic up slightly
    Yahoo Finance5 hours ago

    United Rentals gets an upgrade, Blackberry dips, Medtronic up slightly

    United Rentals, Blackberry and Medtronic are the Yahoo Finance charts of the day.

  • Artificial Intelligence-Powered Sugar.IQ(TM) Diabetes Management App Developed by Medtronic and IBM Watson Health Now Commercially Available
    GlobeNewswire50 minutes ago

    Artificial Intelligence-Powered Sugar.IQ(TM) Diabetes Management App Developed by Medtronic and IBM Watson Health Now Commercially Available

    June 22, 2018 - Medtronic plc (MDT), the global leader in medical technology, services and solutions, and its strategic technology partner, IBM (NYSE:IBM) Watson Health, today announced commercial availability of the Sugar.IQ(TM) smart diabetes assistant, a first-of-its-kind intelligent app designed to simplify and improve daily diabetes management. Approximately 30.3 million Americans have been diagnosed with diabetes, with 1.5 million new cases being diagnosed every year.1 More than 6 million of those impacted use insulin to manage their diabetes.2 People with diabetes face many daily challenges - managing their condition, understanding medical advice, knowing what to eat and when, the impact of food and activity on sugar levels, and trying to avoid critical glycemic events.

  • Big News Sends Tandem Diabetes Soaring 10.2% Today
    Motley Fool6 hours ago

    Big News Sends Tandem Diabetes Soaring 10.2% Today

    The FDA has given the OK to the company's automated insulin system.

  • Benzinga9 hours ago

    Tandem Diabetes Rallies After FDA Approves Insulin Pump With New Technology

    The medical device maker announced Thursday the FDA approved its t:slim X2 Insulin pump with Basal-IQ technology. Tandem Diabetes expects to make the t:slim X2 pump with Basal-IQ technology available in the U.S. in August.

  • Benzinga10 hours ago

    Benzinga's Daily Biotech Pulse: FDA Greenlights Tandem Diabetes' Insulin Pump, More IPOs On Tap

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on June 21) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) FibroGen Inc (NASDAQ: ...

  • CNBC11 hours ago

    Stocks making the biggest moves premarket: BB, MDT, URI, JPM, BAC & more

    BlackBerry BB-CA – BlackBerry reported adjusted first-quarter profit of 3 cents per share, compared to analysts' expectations of a breakeven quarter. JPMorgan Chase JPM , Bank of America BAC , Citigroup C , Wells Fargo WFC – These and other bank stocks are on watch today after 35 of the nation's largest banks passed the Fed's latest stress tests. The software provider's revenue also beat forecasts on strong demand from large companies, but its current-quarter and full-year revenue forecasts are short of analysts' estimates due to a strengthening dollar.

  • MarketWatch12 hours ago

    Medtronic raises quarterly dividend 9% to 50 cents a share

    MARKET PULSE Medtronic Plc (mdt) said Friday its board has approved a 9% increase in its quarterly cash dividend to 50 cents a share. The new dividend payment will be made on July 25 to shareholders of record as of July 6.

  • Medtronic Announces 9 Percent Increase In Cash Dividend
    GlobeNewswire12 hours ago

    Medtronic Announces 9 Percent Increase In Cash Dividend

    June 22, 2018 - The board of directors of Medtronic plc (MDT) today approved a 9 percent increase in its quarterly cash dividend, raising the quarterly amount to $0.50 per ordinary share. This would translate into an annual amount of $2.00 per ordinary share, or a dividend per share payout ratio of 42 percent of prior fiscal year non-GAAP diluted earnings per share (EPS). Today`s announcement marks the 41st consecutive year of an increase in the dividend payment for Medtronic, a constituent of the S&P 500 Dividend Aristocrats index.

  • American City Business Journals13 hours ago

    How have Minnesota's top employers fared in hiring surge? Depends on whether they're in retail

    May marked the 92nd straight month in which U.S. employers added workers to their collective ranks. However, Minnesota's biggest public companies aren't all adding employees.

  • Medtronic Receives FDA Approval of New Pediatric Indication for the MiniMed(TM) 670G Hybrid Closed Loop System in Children Ages 7-13
    GlobeNewswireyesterday

    Medtronic Receives FDA Approval of New Pediatric Indication for the MiniMed(TM) 670G Hybrid Closed Loop System in Children Ages 7-13

    DUBLIN- June 21, 2018 - Medtronic plc (MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the use of the MiniMed(TM) 670G system in patients with type 1 diabetes seven years of age and older. This newest system by Medtronic features the company`s most advanced SmartGuard(TM) technology and most accurate CGM - the Guardian Sensor 3 - which work together to automate the delivery of a personalized amount of basal insulin every five minutes based on sensor glucose values. "The MiniMed 670G system is the most advanced insulin delivery system on the market today and proven to effectively manage type 1 diabetes," said Dr. Jennifer Sherr, a pediatric endocrinologist at Yale New Haven Children`s Hospital`s diabetes clinic and an associate professor of pediatric endocrinology at the Yale School of Medicine.